Antibody Therapy Effective in Immunodeficient COVID-19 Patients
Patients with immunodeficiency-associated antibody disorders and a longstanding SARS-CoV-2 infection improved substantially after receiving compassionate-use casirivimab and imdevimab, a new study shows.
Reuters Health Information
source https://www.medscape.com/viewarticle/966136?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/966136?src=rss
Comments
Post a Comment